Outlook Therapeutics Inc. (OTLK) at a glance

Outlook Therapeutics Inc. (OTLK) is a Healthcare company. It trades at $1.17. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (35/100).

Price
$1.17
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$0.16 to $3.39
Vestovix Score49/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
35